Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma
Mepolizumab depletes inflammatory eosinophils (iEOs) but preserves a residual population of homeostatic eosinophils (hEOs) in severe asthma. In contrast benralizumab treatment fully depletes both...
onlinelibrary.wiley.com